Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 661,497 | 516,273 | 635,280 | 1,347,186 | 1,291,366 |
| Receivables | 123,657 | 394,890 | 112,849 | 82,375 | 111,645 |
| Inventories | 69,592 | 23,488 | 34,185 | 36,683 | 82,432 |
| TOTAL | $1,006,764 | $1,127,554 | $971,028 | $1,703,391 | $1,759,965 |
| Non-Current Assets | |||||
| PPE Net | 300,982 | 299,955 | 307,414 | 294,247 | 255,532 |
| Intangibles | 123,780 | 128,366 | 129,827 | 126,331 | 125,991 |
| Other Non-Current Assets | 225,631 | 129,173 | 134,430 | 134,710 | 125,949 |
| TOTAL | $650,393 | $557,494 | $571,671 | $555,288 | $507,472 |
| Total Assets | $1,657,157 | $1,685,048 | $1,542,699 | $2,258,679 | $2,267,437 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 101,914 | 87,246 | 124,801 | 216,517 | 144,997 |
| Accrued Expenses | 311,201 | 458,397 | 518,706 | 591,158 | 551,069 |
| Other current liabilities | 861,956 | 749,186 | 858,382 | 930,055 | 160,499 |
| TOTAL | $1,468,590 | $1,596,255 | $1,918,858 | $2,459,944 | $1,667,961 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 192,187 | 300,473 | 415,764 | 370,137 | 404,776 |
| Other Non-Current Liabilities | 204,917 | 205,631 | 214,368 | 222,161 | 98,569 |
| TOTAL | $866,917 | $843,312 | $519,423 | $432,813 | $1,165,461 |
| Total Liabilities | $2,335,507 | $2,439,567 | $2,438,281 | $2,892,757 | $2,833,422 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 118,790 | 94,404 | 86,305 | 86,173 | 78,504 |
| Common Shares | 1,196 | 952 | 871 | 868 | 792 |
| Retained earnings | -4,642,562 | -4,511,786 | -4,569,794 | -4,275,889 | -4,093,640 |
| Other shareholders' equity | -11,569 | -8,601 | -3,392 | -6,036 | -23,734 |
| TOTAL | $-678,350 | $-754,519 | $-895,582 | $-634,078 | $-565,985 |
| Total Liabilities And Equity | $1,657,157 | $1,685,048 | $1,542,699 | $2,258,679 | $2,267,437 |